Support and Resistance Levels
Past performance
About Marksans Pharma Ltd Marksans Pharma Limited, established in April 1982, is primarily involved in the research, manufacture, marketing, and sale of pharmaceutical formulations. The company operates R&D facilities in Verna, Goa, and Navi Mumbai. Over the years, Marksans has expanded through strategic acquisitions, including Nova Pharmaceuticals Australasia in 2005, Bell Sons & Company, and Relonchem Limited in the UK in 2008, and Time-Cap Laboratories in the US in 2015. The company received its first ANDA approval in the US in 2011 and launched the CNS-Cerebella division in FY 2017-18, focusing on niche soft gelatin capsules.
In 2019-20, Marksans commissioned a new R&D center in Navi Mumbai. Most recently, in April 2023, the company acquired Tevapharm India Private Limited's pharmaceutical manufacturing business in Verna, Goa. These developments signify Marksans' continued focus on innovation and expansion in the global pharmaceutical market.